A new IDSA guideline for seasonal influenza in adults and children provides evidence-based recommendations for diagnosis, treatment, chemoprophylaxis, and institutional outbreak management.

The Centers for Disease Control and Prevention (CDC) is advising acute care facilities to take steps to control the spread of carbapenem-resistant Enterobacteriaceae (CRE) now, before these deadly and hard-to-treat pathogens become widespread.

A major barrier to new antibiotic development has come down: The Food and Drug Administration (FDA) has released long-awaited guidance for companies developing drugs for the therapy of community-acquired pneumonia (CAP).

This month: nephrotoxicity of adjunctive gentamicin; fluoroquinolone-resistant meningitis; declining MRSA CLABSIs; inactivated flu vaccine outperforms live-attenuated vaccine in healthy adults; multidrug-resistant gram-negatives on the rise; and possible new drugs for XDR TB.

IDSA Membership Renewal
Renew your IDSA membership for 2009!

Society Awards application deadline
April 1, 2009 (5:00 p.m. EST)

Advancement to Fellow application deadline
April 1, 2009 (5:00 p.m. EST)

IDSA 47th Annual Meeting October 29-November 1, 2009 Philadelphia, PA Abstract Submission deadline - May 20, 2009 Discounted registration for members only deadline - July 31, 2009